Johnson & Johnson Covid-19 Booster Shot Bolsters Immune Defense, FDA Staff Say

France Nouvelles Nouvelles

Johnson & Johnson Covid-19 Booster Shot Bolsters Immune Defense, FDA Staff Say
France Dernières Nouvelles,France Actualités
  • 📰 WSJ
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

A booster shot of Johnson & Johnson’s Covid-19 vaccine showed signs of significantly bolstering the immune defenses of study subjects, said FDA regulators, who cautioned that their data was limited

A booster of Johnson & Johnson ’s Covid-19 vaccine showed signs of significantly bolstering the immune defenses of study subjects, federal health regulators said Wednesday.

The regulators cautioned, however, that data was limited and they had to rely on J&J’s own analysis for some of the study findings, rather than conducting their own.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

WSJ /  🏆 98. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Where America's cases, hospitalizations, deaths stand 19 months into the COVID-19 pandemicWhere America's cases, hospitalizations, deaths stand 19 months into the COVID-19 pandemicAlthough hospitalizations nationwide have been trending downward since September, more than 40,000 people remain hospitalized with COVID-19.
Lire la suite »

Merck Seeks FDA Authorization for Antiviral COVID-19 PillMerck Seeks FDA Authorization for Antiviral COVID-19 PillDrugmaker Merck announced Monday that it submitted an application to the FDA for emergency use authorization of molnupiravir, an experimental antiviral COVID-19 treatment.
Lire la suite »

FDA Staff Don’t Take Position on Moderna Covid-19 BoosterFDA Staff Don’t Take Position on Moderna Covid-19 BoosterIn an unusual move, FDA staff didn't take a position on Moderna's application for a booster shot, indicating there may be insufficient data to support one
Lire la suite »

U.S. FDA staff says Moderna did not meet all criteria for COVID-19 boostersU.S. FDA staff says Moderna did not meet all criteria for COVID-19 boostersScientists at the U.S. Food and Drug Administration said on Tuesday that Moderna Inc had not met all of the agency's criteria to support use of booster doses of its COVID-19 vaccine, possibly because the efficacy of the shot's first two doses has remained strong.
Lire la suite »

Moderna has no plans to share its COVID-19 vaccine recipeModerna has no plans to share its COVID-19 vaccine recipeModerna's chairman, Noubar Afeyan, says the company won't share the recipe for its COVID-19 vaccine because scaling up its own production is the best way to increase the global supply. The U.N. health agency has pressed Moderna to share its formula.
Lire la suite »

COVID-19 live updates: Daily death average nearly 8 times higher than in mid-JulyCOVID-19 live updates: Daily death average nearly 8 times higher than in mid-JulyLATEST: All in-person runners must be fully vaccinated two weeks ahead of next month's Philadelphia Marathon, officials announce. Runners with only a negative test won't qualify.
Lire la suite »



Render Time: 2025-03-23 04:03:18